Related references
Note: Only part of the references are listed.Greater Sensitivity of Blood Pressure Than Renal Toxicity to Tyrosine Kinase Receptor Inhibition With Sunitinib
Stephanie Lankhorst et al.
HYPERTENSION (2015)
Association Studies Suggest a Key Role for Endothelin-1 in the Pathogenesis of Preeclampsia and the Accompanying Renin-Angiotensin-Aldosterone System Suppression
Koen Verdonk et al.
HYPERTENSION (2015)
FDA-approved small-molecule kinase inhibitors
Peng Wu et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Hypertension During Vascular Endothelial Growth Factor Inhibition: Focus on Nitric Oxide, Endothelin-1, and Oxidative Stress
Stephanie Lankhorst et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Treatment of Hypertension and Renal Injury Induced by the Angiogenesis Inhibitor Sunitinib Preclinical Study
Stephanie Lankhorst et al.
HYPERTENSION (2014)
β-Arrestin-1 Drives Endothelin-1-Mediated Podocyte Activation and Sustains Renal Injury
Simona Buelli et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Mechanism of hypertension and proteinuria during angiogenesis inhibition: evolving role of endothelin-1
Stephanie Lankhorst et al.
JOURNAL OF HYPERTENSION (2013)
Endothelin as a final common pathway in the pathophysiology of preeclampsia: therapeutic implications
Eric M. George et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2012)
Sunitinib-Induced Systemic Vasoconstriction in Swine Is Endothelin Mediated and Does Not Involve Nitric Oxide or Oxidative Stress
Mariette H. W. Kappers et al.
HYPERTENSION (2012)
eNOS Deficiency Acts through Endothelin to Aggravate sFlt-1-Induced Pre-Eclampsia-Like Phenotype
Feng Li et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Vascular Endothelial Growth Factor (VEGF), VEGF Receptors and Their Inhibitors for Antiangiogenic Tumor Therapy
Satoru Takahashi
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
The role of tumour-derived iNOS in tumour progression and angiogenesis
V. Kostourou et al.
BRITISH JOURNAL OF CANCER (2011)
The Vascular Endothelial Growth Factor Receptor Inhibitor Sunitinib Causes a Preeclampsia-Like Syndrome With Activation of the Endothelin System
Mariette H. W. Kappers et al.
HYPERTENSION (2011)
Distinct Actions of Endothelin A-Selective Versus Combined Endothelin A/B Receptor Antagonists in Early Diabetic Kidney Disease
Mohamed A. Saleh et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
Brian I. Rini et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Vascular Endothelial Growth Factor Inhibitor-Induced Hypertension: Basics for Primary Care Providers
Carmen P. Escalante et al.
CARDIOLOGY RESEARCH AND PRACTICE (2011)
Hypertension Induced by the Tyrosine Kinase Inhibitor Sunitinib Is Associated With Increased Circulating Endothelin-1 Levels
Mariette H. W. Kappers et al.
HYPERTENSION (2010)
Ambulatory Monitoring Detects Sorafenib-Induced Blood Pressure Elevations on the First Day of Treatment
Michael L. Maitland et al.
CLINICAL CANCER RESEARCH (2009)
Vascular Endothelial Growth Factor Receptor 2 Controls Blood Pressure by Regulating Nitric Oxide Synthase Expression
Carie S. Facemire et al.
HYPERTENSION (2009)
ETA Receptor Blockade With Atrasentan Prevents Hypertension With the Multitargeted Tyrosine Kinase Inhibitor ABT-869 in Telemetry-instrumented Rats
Patricia N. Banfor et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2009)
VEGF inhibition and renal thrombotic microangiopathy
Vera Eremina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
VEGF-targeted therapy: mechanisms of anti-tumour activity
Lee M. Ellis et al.
NATURE REVIEWS CANCER (2008)
Autocrine VEGF signaling is required for vascular homeostasis
Sunyoung Lee et al.
CELL (2007)
Endothelin-1-induced signaling pathways in vascular smooth muscle cells
Ali Bouallegue et al.
CURRENT VASCULAR PHARMACOLOGY (2007)
VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature
T Kamba et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Endothelin-1 triggers placental oxidative stress pathways: Putative role in preeclampsia
G Fiore et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Vascular endothelial growth factor: Basic science and clinical progress
N Ferrara
ENDOCRINE REVIEWS (2004)
Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo
D Salani et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
